Navigation Links
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Date:7/24/2012

f an additional three products.  Our executive offices are located in Blue Bell, PA.  Additional information may be found on the company's website at www.relmada.com.  

About Laidlaw & Company, LTD.

Laidlaw & Company is a full service investment bank and securities brokerage firm with offices in New York, London, San Francisco and select additional locations.  Its corporate finance efforts are focused on the healthcare, natural resource and social commerce sectors.  In addition to capital raising, its investment banking arm provides M&A, restructuring and other financial advisory services for public and private small cap and middle market clients across a broad cross‐section of industry sectors.  Its brokerage arm provides wealth management services for domestic and international high‐net‐worth and institutional clients.  Laidlaw is authorized by the FSA in the United Kingdom, and is regulated by FINRA in the United States. (Source: http://www.laidlawltd.com).  

Safe Harbor Statement

This release contains forward‐looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Any statements contained herein that do not describe historical facts are forward‐looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward looking statements. The Company assumes no obligation to update or supplement any forward‐looking statements whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Relmada Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... There,s a good reason people over 60 are not ... ages and weakens with time, making the elderly prone ... San Francisco research team now has discovered a reason ... for the inability of blood-forming cells to maintain blood ... identified molecular defects that could be restored for rejuvenation ...
(Date:7/31/2014)... Chemists at Indiana University Bloomington have described the ... a development with potential value for the field ... and photovoltaic cells. , Their paper, "Anion-Induced Dimerization ... and 2D Self-Assembled Crystals," has been published online ... the Royal Society of Chemistry. It is the ...
(Date:7/31/2014)... Yonkers, NY (PRWEB) July 31, 2014 ... use in high temperature oven carts. These bearings are ... occur in sealed ball bearings because of the ... purity alumina requested help from the design engineers at ... through a heating process. During their manufacturing operation, pans ...
(Date:7/31/2014)... July 31, 2014 CollabRx, Inc. (NASDAQ: ... therapeutic decision-making in oncology, today announced that it will ... to discuss the Company's financial results for the first ... about the business in the current fiscal year. , ... on Thursday, August 14, 2014, at 5 p.m. EDT ...
Breaking Biology Technology:Key to aging immune system is discovered 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2
... 2011 Informex , the leading meeting place ... details of the Global Pharma Sourcing Conference to be ... Avenue in Philadelphia, Pennsylvania. The two day program will ... CPhI to address key issues that global chemical and ...
... The following is a letter to shareholders from ... a publicly traded portfolio of biotech companies based on ... Dear Fellow Investors, Hadasit Bio-Holdings ... Hadassah University Hospital and its IPO which made public ...
... of recent salmonella outbreaks in the United States: ground ... and the list goes on, according to the U.S. ... for long, thanks to a promising new biosensor nanotechnology ... contaminated food or animals reach the marketplace. In the ...
Cached Biology Technology:Informex Introduces a Thorough Global Pharma Perspectives Conference 2Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 2Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 3Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 4Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 5Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 6
(Date:8/1/2014)... -- LiveScan Service Provider Binary Biometrics is pleased to welcome Kevin ... will improve its mobile service capabilities and add more daily appointments, which will ... service several new cities such as, but not limited to, Daytona ... Deltona , Edgewater , Holly ... Beach , Oak Hill , Orange City ...
(Date:7/31/2014)... by the National Science Foundation (NSF), counters a ... atmospheric warming, indicating instead that certain Arctic lakes ... the atmosphere. , The study, published this ... on thermokarst lakes, which occur as permafrost thaws ... fresh water, converting what was previously frozen land ...
(Date:7/31/2014)... (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity ... (HPV) vaccine Cervarix. Women vaccinated with the ... than nine years, and vaccine efficacy (VE) ... the longest follow-up report for a licensed ... the full paper. , HPV and ...
Breaking Biology News(10 mins):Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 2Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 3Certain Arctic lakes store more greenhouse gases than they release 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3
... the membrane of human liver cells that aids in cholesterol ... first step in hepatitis C infection, according to research at ... The cholesterol receptor offers a promising new target for anti-viral ... the researchers, whose findings were reported online in advance of ...
... has taken us a step closer to breeding hardier crops ... off attack from parasites. In a paper published in ... of the United States of America (PNAS), the researchers have ... Arabidopsis thaliana , or thale cress, by controlling an ...
... infants are helpless creatures that only blink, eat, cry ... studies indicate infant brains come equipped with knowledge of ... we study infant knowledge of the world by measuring ... Kristy vanMarle, an assistant professor in the Department of ...
Cached Biology News:Entry point for hepatitis C infection identified 2Improving crops from the roots up 2Babies are born with 'intuitive physics' knowledge, says MU researcher 2
... The Brownlee Precision Model 440 incorporates ... circuitry in a friendly easy-to-use instrument. Each ... amplifier, an 8-pole Bessel lowpass filter, a ... output offset controls. A control knob sets ...
... versatile & modular instrument which can be used ... Extracellular, Transducer & Multi-channel Isolated Amplification ... Supply unit (NL900D) forms the heart of every ... by this unit, but wiring within the case ...
Rat Epidermal Keratinocytes (REK) (>500,000 cells)...
... The Brownlee Precision Model 410 is a ... used to amplify small signals from sources which ... frequency noise. Each channel consists of a high ... 2-pole lowpass filter, and an output offset control. ...
Biology Products: